Dr. Denis Claude Roy

Affiliation

Full professor of medicine, University of Montreal
Chief executive officer, CellCAN
Scientific director, Centre of Excellence for Cellular Therapy, Montreal’s Maisonneuve-Rosemont Hospital

Committee membership

Stem Cell Oversight Committee

Biography

Denise Claude Roy is a full professor of medicine at the University of Montreal, the chief executive officer of CellCAN (a knowledge mobilization network in the field of regenerative medicine and cell therapy), and a research supervisor at the East Montreal Integrated University Health and Social Services Centre. He is the scientific director of the Centre of Excellence for Cellular Therapy (CECT) at Montreal’s Maisonneuve‑Rosemont Hospital, where a unit for viral vector production and cell transduction with good manufacturing practices (GMP)-compliant infrastructure was recently created.

Dr. Roy has received training in tumour immunology at Dana‑Farber Cancer Institute in Boston, MA. His translational and clinical research focuses on cell manipulation to improve the clinical impact of stem cell transplantation, cancer immunotherapy and regenerative medicine. The primary goal of his work is to develop cancer immunotherapy and immune tolerance strategies. He has led more than 15 national and international phase I, II and III clinical trials on cell therapy and had more than 130 original articles and chapters included in prestigious publications. Dr. Roy is also the scientific director of the C3i centre for the commercialization of cancer immunotherapy and regenerative medicine, as well as co‑director of the Quebec cell, tissue and gene therapy network TheCell (Quebec Research Fund – Health).

Date modified:

2020-01-24